CORPAY INC
CPAYNYSE🏆 #445 by market capEarnings Nov 4 · PostUS Equity
$395.86▼ $1.15 (−0.29%)
Market closed · at closeTrack CPAY
Get earnings, price moves & breaking news on Telegram
24h▼ 0.3%
7d▼ 4.6%
14d▼ 2.6%
30d▲ 0.8%
ytd▲ 31.6%
1y▲ 47.7%
🏦Market Cap
$25.99B
Mid Cap
📈Revenue Growth (YoY)
20.4%
Healthy
📊Gross Margin
79.0%
High
💵FCF Margin
43.3%
Strong
⚖️P/S Ratio
5.2x
Fair
Otter Score
84
Strong
CORPAY INC
CPAYAnalyst Ratings
Price
$395.86
Total
18
Raised
0
Lowered
0
Avg PT
$457.00
H / L
$536 / $388
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Morgan Stanley | Reiterated | Overweight | 2026-10-28 | $460.00 | +16.20% |
RBC Capital | Reiterated | Sector Perform | 2026-08-31 | $438.00 | +10.60% |
Wolfe Research | Reiterated | Outperform | 2026-08-25 | $530.00 | +33.90% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-10 | $480.00 | +21.30% |
Keefe, Bruyette & Woods | Reiterated | Outperform | 2026-08-06 | — | — |
UBS | Reiterated | Neutral | 2026-08-06 | $415.00 | +4.80% |
JP Morgan | Reiterated | Overweight | 2026-08-06 | — | — |
Baird | Reiterated | Outperform | 2026-03-31 | — | — |
Mizuho | Reiterated | Neutral | 2026-02-06 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-01-12 | $388.00 | −2.00% |
Raymond James | Reiterated | Outperform | 2025-08-07 | $442.00 | +11.70% |
Wells Fargo | Reiterated | Equal Weight | 2025-04-24 | $285.00 | −28.00% |
Barclays | Reiterated | Overweight | 2025-04-14 | $330.00 | −16.60% |
BMO Capital | Reiterated | Outperform | 2024-12-13 | $400.00 | +1.00% |
Citigroup | Reiterated | Buy | 2024-11-14 | — | — |
Jefferies | Reiterated | Buy | 2024-10-16 | — | — |
B of A Securities | Reiterated | Buy | 2024-10-15 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2024-06-25 | — | — |
Institution
Morgan Stanley
Reiterated · Overweight · 2026-10-28
$460.00
+16.20%
RBC Capital
Reiterated · Sector Perform · 2026-08-31
$438.00
+10.60%
Wolfe Research
Reiterated · Outperform · 2026-08-25
$530.00
+33.90%
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-10
$480.00
+21.30%
Keefe, Bruyette & Woods
Reiterated · Outperform · 2026-08-06
—
—
UBS
Reiterated · Neutral · 2026-08-06
$415.00
+4.80%
JP Morgan
Reiterated · Overweight · 2026-08-06
—
—
Baird
Reiterated · Outperform · 2026-03-31
—
—
Mizuho
Reiterated · Neutral · 2026-02-06
—
—
Oppenheimer
Reiterated · Outperform · 2026-01-12
$388.00
−2.00%
Raymond James
Reiterated · Outperform · 2025-08-07
$442.00
+11.70%
Wells Fargo
Reiterated · Equal Weight · 2025-04-24
$285.00
−28.00%
Barclays
Reiterated · Overweight · 2025-04-14
$330.00
−16.60%
BMO Capital
Reiterated · Outperform · 2024-12-13
$400.00
+1.00%
Citigroup
Reiterated · Buy · 2024-11-14
—
—
Jefferies
Reiterated · Buy · 2024-10-16
—
—
B of A Securities
Reiterated · Buy · 2024-10-15
—
—
Evercore ISI Group
Reiterated · Outperform · 2024-06-25
—
—
One row per institution · price target from the firm's latest published target